Skip to main content
HCAT logo

HCAT · Health Catalyst, Inc. · Investor Relations

Track HCAT — free
$1.75 +0.04 (+2.34%)
Market Cap
$128.69M
Shares
75.26M
Volume · Oct 20 139.58K Avg daily vol (3M) 610.24K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-09-14 Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

SALT LAKE CITY, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that on September 14, 2026, the Compensation Committee of

2026-09-14 Health Catalyst Strengthens Its Board with the Appointment of Tami Reller

Reller Joins Health Catalyst as it Enters Its Next Phase of Growth SALT LAKE CITY, Sept. 14, 2026 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst", NASDAQ: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Tami

2026-09-08 Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President

Kohl brings public-company leadership and a record of successful transformation; Ben Albert to continue as Chief Business Officer SALT LAKE CITY, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed

2026-08-31 Health Catalyst to Participate in Upcoming Investor Conference

SALT LAKE CITY, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the 2026 Wells Fargo

2026-08-06 Health Catalyst Reports Second Quarter 2026 Results

SALT LAKE CITY, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended June 30, 2026.

2026-08-06 Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

Company retires all credit facility debt; transaction reflects concentrating its technology on improving health system performance. SALT LAKE CITY, Aug. 6, 2026 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company," Nasdaq: HCAT), a healthcare intelligence company designed to

2026-07-28 Health Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026

SALT LAKE CITY, July 28, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its second quarter 2026 operating results on Thursday, August 6, 2026, after

2026-06-16 Health Catalyst to Participate in Upcoming Investor Conference

SALT LAKE CITY, June 16, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the Truist Securities

2026-06-04 Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation

Transaction reflects a sharper focus on AI and core technology; net proceeds expected to strengthen balance sheet and provide financial flexibility SALT LAKE CITY, June 04, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT) today announced it has

2026-05-11 Health Catalyst Reports First Quarter 2026 Results

SALT LAKE CITY, May 11, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended March 31, 2026.

2026-05-01 Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026

SALT LAKE CITY, May 01, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its first quarter 2026 operating results on Monday, May 11, 2026, after market

2026-04-30 Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors

Nelson Joins as the Company Builds the Leadership Infrastructure for Its Next Phase SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today

2026-03-12 Health Catalyst Reports Fourth Quarter and Year End 2025 Results

SALT LAKE CITY, March 12, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2025.

2026-03-02 Health Catalyst to Announce Fourth Quarter and Year End 2025 Operating Results and Host Conference Call on Thursday, March 12, 2026

SALT LAKE CITY, March 02, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and year end 2025 operating results on Thursday, March 12, 2026,

2026-02-18 Health Catalyst Appoints Ben Albert as Chief Executive Officer

Albert to Sharpen Focus on Improving Cost and Operational Efficiency, Clinical Quality, and Consumer Experience in Healthcare Health Catalyst Board to be Reduced to Five Directors Immediately Prior to the 2026 Annual Meeting SALT LAKE CITY, Feb. 18, 2026 /PRNewswire/ -- Health Catalyst, Inc.

2025-12-02 Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors

SALT LAKE CITY , Dec. 2, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Matt Arens , CEO and Founder of First Light Asset Management,

2025-11-14 Health Catalyst to Participate in Upcoming Investor Conferences

SALT LAKE CITY, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming

Past events

Date Event Type
2026-08-06 Health Catalyst, Inc. Q2 2026 Earnings Conference Call Earnings call
2026-06-24 Truist Securities Healthcare Disruptors & Digital Health Conference Conference
2026-05-11 Health Catalyst, Inc. Q1 2026 Earnings Conference Call Earnings call
2026-03-12 Health Catalyst Fourth Quarter & Full Year 2025 Earnings Earnings call
2025-12-03 Citi’s 2025 Global Healthcare Conference Conference
2025-12-03 Citi's 2025 Global Healthcare Conference Conference
2025-12-02 The 8th Annual Evercore Healthcare Conference Conference
2025-12-02 8th Annual Evercore Healthcare Conference Conference
2025-11-20 The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum Conference
2025-11-20 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum Event
2025-11-19 The Stephens Annual Investment Conference Conference
2025-11-19 Stephens Annual Investment Conference Conference
2025-11-10 Health Catalyst, Inc. Q3 2025 Earnings Conference Call Earnings call
2025-09-04 Wells Fargo Healthcare Conference Conference
2025-08-26 Health Catalyst Analytics Summit IR Dinner Event

Source: https://ir.healthcatalyst.com/

Key facts CIK 1636422 CUSIP 42225T107 13F (30d) 9 filings 9 filers Visit website Investor relations